Category Archives: FDA

#DigitalHealth: Remote Patient Monitoring Part 3: The Ideal RPM System

Posted on March 29, 2013 by

Remote patient monitoring may serve patients who are in the post-acute care phase of recovery from a hospitalization as well as those with chronic diseases.  Monitoring may consist of communication tools or measurements of medication adherence, glucose measurements for diabetics, … Continue reading →

About these ads
Posted in digital health, FDA, informatics, medical devices, mHealth, mobile health, remote patient monitoring, technology, telehealth | Tagged , , , , , , | Leave a comment

#DigitalHealth: Remote Patient Monitoring, Part 2- Operational Models

Posted on March 25, 2013 by

In my previous post, I discussed some generalities of remote patient monitoring (RPM).  The current value of the RPM market is estimated at $10.6B. There are diverse clinical and non-clinical environments in which RPM might be utilized.  The healthcare ecosystem is … Continue reading →

Posted in digital health, FDA, Implantable Defibrillators, informatics, mobile health, remote patient monitoring, wireless health | Tagged , , , , , , | 2 Comments

#DigitalHealth: Five Fallacies of Remote Patient Monitoring

Posted on March 15, 2013 by

As defined in Wikipedia, remote patient monitoring (RPM) is: “a technology to enable monitoring of patients outside of conventional clinical settings (e.g. in the home), which may increase access to care and decrease healthcare delivery costs.”  I was a pioneer … Continue reading →

Posted in mHealth, Healthcare IT, technology, mobile health, informatics, medical devices, wireless health, telehealth, digital health, FDA, medical apps | Tagged , , , , , , , , , , , | 5 Comments

Five Pitfalls of Designing a Medical App

Posted on January 31, 2013 by

There are an estimated 15,000 medical apps presently on the market and is expected to grow 25% per year according to one study.  There are issues which are common in the development of these apps and other categories of apps. … Continue reading →

Posted in digital health, FDA, informatics, medical apps, mHealth, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , , , , , , | 6 Comments

Business Models of Digital Health Technologies: Implications for ROI

Posted on January 11, 2013 by

In my last post I discussed problems with measuring the ROI of digital health technologies.  One of the problems is that the sector doesn’t fit neatly into traditional healthcare business models. There have been multiple articles  written about business models … Continue reading →

Posted in digital health, FDA, Healthcare IT, healthcare vendors, medical devices, mHealth, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , , , , | 2 Comments

Five Big Developments for Digital Health in 2013

Posted on December 31, 2012 by

I read with interest a few articles discussing predictions for digital health technologies for 2013.  One such amusing article in informationweek.com had some which were in more detailed described as  By the end of 2013, the implementation of such a … Continue reading →

Posted in FDA, healthcare economics, Healthcare IT, healthcare reform, informatics, medical apps, medical devices, smartphone apps, telehealth | Tagged , , , , , , , , | 5 Comments

The Healthcare Cliff

Posted on December 6, 2012 by

The term ‘fiscal cliff’ is one familiar to most Americans and many outside observers of this periodic political posturing around the need to address hardcore financial issues facing the country.  If both political parties hashed out their differences and came … Continue reading →

Posted in digital health, FDA, health insurance, healthcare economics, healthcare reform, informatics, medical apps, mHealth, mobile health, technology, wireless health | Tagged , , , , , , , , , , | 1 Comment

Why Payers are Critical to mHealth Adoption

Posted on December 2, 2012 by

     In previous posts I have talked about the importance of some of the major stakeholders in mHealth adoption (Physicians, non-physician providers,hospitals, and caregivers) in mHealth adoption. For a few reasons insurers will also play a pivotal role in … Continue reading →

Posted in clinical trials, digital health, FDA, health insurance, healthcare economics, informatics, medical apps, mHealth, mobile health, smartphone apps, wireless health | Tagged , , , , , , , , , | 1 Comment

The Future of Medical Apps: A Call to Arms For the End of Flimsy Science

Posted on November 19, 2012 by

A recent article in the Washington Post raises concerns about the legitimacy of mobile health apps.  As Chair of the committee which developed Draft Standards for the Happtique App Certification Program, I applaud the author for taking a critical look … Continue reading →

Posted in clinical trials, digital health, FDA, healthcare economics, medical apps, medical devices, mHealth, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , , | 4 Comments

The FDA and Medical Apps: Where are We?

Posted on November 5, 2012 by

In a previous post on this site I discussed my reasons for endorsing FDA oversight of mobile medical apps. Since we are nearing a final decision by the FDA concerning the matter, I thought it fitting to bring it to … Continue reading →

Posted in digital health, FDA, Healthcare IT, healthcare reform, medical apps, mHealth, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , | 3 Comments